If you or a loved one suffered from excessive bleeding while taking the drug Pradaxa, you may be eligible for damages.
Pradaxa is a blood thinning drug that has been prescribed to treat patients with non-vascular atrial fibrillation or AFib. These second generation blood thinners have been touted and marketed as a safe and effective alternative to Warfarin (Coumadin) which has been used for many years to treat patients with AFib and other health conditions.
This drug has been linked to an increased risk of injury that includes severe bleeding. Once bleeding begins, this drug lacks the necessary antidote or counteracting agent to reverse it’s effect making bleeding in many cases uncontrollable and severe. Unfortunately, there have been many cases of death associated with these side effects.
Pradaxa (dabigatran) was brought to market by the Boehringer Ingelheim company in 2010. In 2014, the FDA published a study showing that Pradaxa had an increased risk of gastrointestinal bleeding compared to Warfarin. (Click here to read the study.) Thousands of individuals who allege they were injured by Pradaxa filed claims and lawsuits against Boehringer Ingelheim. In these lawsuits, evidence was developed that show that Boehringer Ingelheim failed to share data it had regarding the increased risk of bleeding. The company has just recently paid $650 million dollars to settle the claims and lawsuits of individuals who suffered injuries as a result of taking Pradaxa.
If you or a loved one has suffered an injury related to taking Pradaxa including but not limited to the following, the lawyers at Burke Harvey stand ready to assist you:
- Gastrointestinal bleeding or hemorrhage
- Brain bleeding or hemorrhage
- Uncontrolled internal bleeding or hemorrhage
- Stroke or Heart Attack
Burke Harvey represents hundreds of individuals and their families who have suffered injuries or death related to use of Pradaxa. Contact Burke Harvey today to get the help you need.